Navigation Links
Pfizer Global R&D Presents 2008 Top Intermediates CMO Award to Asymchem

May 1, 2009 in Groton, Connecticut

MORRISVILLE, N.C., May 20 /PRNewswire/ -- Asymchem Laboratories, Inc., a leading research-based contract manufacturer of APIs, intermediates and Drug Products to the pharmaceutical industry, with sites in the U.S. and China, is pleased to announce the recent award by Pfizer Inc. as the 2008 Top Intermediates CMO Award.

The award was presented at Pfizer's Groton, Connecticut R&D center on May 1, 2009. The award was the first in an annual series to be presented to high performing chemical intermediates suppliers. "A global network of high-quality chemical intermediate manufacturers is critical to enable Pfizer to create and sustain a competitive advantage," said Laurie Chipperfield, Director of API Strategic Sourcing.

Ed Kobelski, Global VP Supply Chain at Pfizer, presented the award to Dr. Hao Hong, CEO of Asymchem. "The steady growth of Asymchem's business at Pfizer is the result of their successful execution of each project, ability to achieve R&D speed targets, excellent customer service and high technical proficiency," stated Dr. Kobelski.

Pfizer uses a quantitative/qualitative supplier performance assessment process that combines performance data along with feedback from internal R&D and commercial project managers. Supplier excellence is judged on criteria including supplier value, delivery, account support, and compliance.

"I am very excited and honored to receive this award, and sincerely appreciate Pfizer's recognition of Asymchem's dedicated staff," states Dr Hao Hong, CEO of Asymchem. "By consistently delivering on time and within spec, we help push through projects that are time critical in the clinical arena. Our new Dunhua cGMP commercial production facility coming online later this year will further expand Asymchem's offerings."

The Asymchem headquarters, located in the RTP of North Carolina, coordinates highly technical chemical R&D/manufacturing facilities in China designed to provide integrated services for the pharmaceutical and biotech industries. With a diverse range of capabilities from the synthesis of sophisticated organic chemicals in the lab to commercial scale production of API's, Asymchem offers a comprehensive list of services for pharmaceutical customers. For more on Asymchem, please visit the website:

SOURCE Asymchem Laboratories
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Pfizer and Bristol-Myers Squibb Finalize Agreement for Worldwide Collaboration on Metabolic Disorders Program
2. Former Pfizer Director of Inflammation Molecular Sciences to Spearhead Velcura Therapeutics Inflammatory Disease Initiatives
3. AUDIO from Medialink and Pfizer: Hispanic Heritage Month Reminds Us Increasing Numbers of Hispanic-Americans Do Not Have Health Insurance
4. Pfizer, Genentech, Amgen, Bayer, Wyeth, Abbott, Merck and Additional Leading Pharmaceutical Companies Participating During ExL Pharmas Fall Line Up!
5. Pfizer Animal Health and NTRA Charities Team Up to Benefit the Barbaro Memorial Fund
6. Eisai/Pfizers Aricept Owns a Dominating 42.4% Patient Share for First-Line Treatment of Alzheimers Disease
7. WX Crowned Chemistry CRO of the Year by Pfizer
8. Ingenuity Systems and Pfizer Announce Strategic Partnership for Pathway Analysis
9. QSV Biologics awarded cGMP manufacturing contract by Pfizer Inc.
10. Odyssey Thera Announces Milestone Achievement in Pfizer Alliance
11. Medivation Announces Expiration of Hart-Scott-Rodino Waiting Period for Collaboration With Pfizer
Post Your Comments:
(Date:10/13/2015)... Oct. 13, 2015  According to Kalorama Information, ... reach $102 billion by the end of 2015. ... health industry, as it is estimated that approximately ... laboratory tests. In addition to diagnosing patients, clinical ... disease progression, monitor drug treatment and conditions, and ...
(Date:10/13/2015)... , ... October 13, 2015 , ... ... distributor of automation systems, material handling solutions and components, is opening its latest ... near State Street, the facility is Exotic’s second major expansion in Metropolitan Detroit ...
(Date:10/13/2015)... Charlotte, NC (PRWEB) , ... October 13, 2015 ... ... high intensity focused ultrasound (HIFU) technologies, announced today that it received de novo ... 450 in the U.S. for the ablation of prostate tissue. Sonablate® is ...
(Date:10/13/2015)... , ... October 13, 2015 , ... ... educational opportunities for school age children in the areas of Science, Technology, Engineering ... sectors of the national economy, and the program aims to increase the number ...
Breaking Biology Technology:
(Date:10/12/2015)... 2015 NXTD ) ("NXT-ID" or the ... commerce market, reports on the recent SNS Future in Review ... --> NXTD ) ("NXT-ID" or the "Company"), a biometric ... on the recent SNS Future in Review Conference in ... Inc. (NASDAQ: NXTD ) ("NXT-ID" or the "Company"), a ...
(Date:10/8/2015)... 2015 NXT-ID, Inc. (NASDAQ: ... biometric authentication company focused on the growing mobile ... wallet announces that revenues for the three months ... with $113,00 for the three months ended June ... September 30, 2015 were approximately $520,000. ...
(Date:10/5/2015)... ) releases the following ... NXTD ), a biometric authentication company focused on the ... ) releases the following market and company update ... authentication company focused on the growing mobile commerce market. ... ) releases the following market and company update ...
Breaking Biology News(10 mins):